Latest news
July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing - Clinical LeaderClinical Leader · Fri, 07 Aug 2026 04:06:50 GMTTrump to Impose Generic Drug Tariffs Starting 2028, Testing U.S. Onshoring Ambitions - Profit Margin Analysis - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 03:11:10 GMTTrump Proposes Generic Drug Tariffs Beginning 2028, Granting Two-Year Reprieve to Reshape Pharmaceutical Supply Chains - Earnings Manipulation Risk - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 14:29:36 GMTTrump Plans Generic Drug Tariffs Starting 2028, Two-Year Delay Tests U.S. Onshoring Ambitions - Earnings Surprise Score - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 00:34:57 GMTTrump Plans Generic Drug Tariffs Starting 2028, Two-Year Delay Tests U.S. Onshoring Ambitions - Quarterly Financial Update - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 00:34:57 GMTTrump Proposes Generic Drug Tariffs Beginning 2028, Testing Feasibility of U.S. Onshoring Push - Earnings Season Review - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 17:38:45 GMTTrump Proposes Generic Drug Tariffs Beginning 2028, Testing Feasibility of U.S. Onshoring Push - EPS Estimate Trend - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 17:38:45 GMTTrump Proposes Generic Drug Tariffs Beginning 2028, Testing Feasibility of U.S. Onshoring Effort - Margin Expansion Trends - dars.gov.etdars.gov.et · Fri, 31 Jul 2026 02:17:18 GMT